Yamin Khan

Yamin Khan serves as Chief Executive Officer at hVIVO. hVIVO operates in the research sector with approximately 250.0 employees. The company is headquartered in Ottershaw, England. hVIVO generates annual revenue of 71344000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 10,137 executive contacts are available in England.
• • Our database includes 201,469 c suite-level executives.

Salesforce Rackspace MailGun Mimecast Outlook Pardot Microsoft Office 365 Amazon AWS Remote

clinical trials uk clinical trials clinical research challenge models human challenge models human volunteer research respiratory disease research medical research asthma studies copd influenza human models of disease challenge studies human challenge trials rsv malaria hrv respiratory syncytial virus human rhinoviruse lab services covid 19 biotechnology research infectious diseases respiratory diseases vaccine testing antiviral testing safety & efficacy biopharmaceutical development challenge study models phase ii-iii trials laboratory services bioassays biomarker analysis virology services immunology services quarantine facilities healthy volunteers drug development consultancy patient recruitment clinical data management study design regulatory submissions viral challenge models data collection field trial bio-logistics molecular testing vaccine development challenge agent manufacture immunomodulators influenza models covid-19 research hmpv studies hrv testing malaria trials copd research pharmaceutical r&d early clinical development clinical site services flucamp ethical guidelines participant monitoring study protocol development volunteer safety healthcare research biotechnology solutions clinical performance metrics state-of-the-art facilities specialist contract research organization therapeutic development clinical trial design virology immunology cryostorage regulatory compliance data management biopharmaceuticals ethical practices sustainability market leader innovative solutions operational efficiency patient engagement proof-of-concept studies global biopharma companies revenue growth environmental commitment healthcare innovation health care health wellness & fitness hospital & health care environmental services renewables & environment

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Yamin Khan in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at hVIVO.

How do I reach Yamin Khan directly?

Yamin Khan's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at hVIVO. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Yamin Khan work for?

Yamin Khan is Chief Executive Officer at hVIVO, a company in the research sector with 250.0 employees. The company is based in Ottershaw, England.

Can I pitch or sell to Yamin Khan?

As Chief Executive Officer at hVIVO, Yamin Khan is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Yamin Khan directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Yamin Khan in?

Yamin Khan works in the research industry as Chief Executive Officer at hVIVO. MessageCEO provides verified contact information for executives across all major industries.

Is Yamin Khan's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Yamin Khan's profile is kept up-to-date with the latest available information.

Last updated: May 12, 2026